ArticleCNS drugs2024

Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review.

Amira Salim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.